C1qatm1d(EUCOMM)Wtsi
Targeted Allele Detail
|
Symbol: |
C1qatm1d(EUCOMM)Wtsi |
Name: |
complement component 1, q subcomponent, alpha polypeptide; targeted mutation 1d, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:6151469 |
Gene: |
C1qa Location: Chr4:136623228-136626114 bp, - strand Genetic Position: Chr4, 69.05 cM
|
Alliance: |
C1qatm1d(EUCOMM)Wtsi page
|
IMPC: |
C1qa gene page |
|
Mutant Cell Line: |
EPD0618_1_B03 |
Germline Transmission: |
Earliest citation of germline transmission:
J:101977
|
Parent Cell Line: |
JM8A3.N1 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
EUCOMM
|
|
Allele Type: |
|
Targeted (Null/knockout) |
Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The L1L2_Bact_P cassette was inserted at a position on Chromosome 4 upstream of exon 3 of the gene. The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site was inserted in the 3' untranslated region of exon 3. Flp-mediated recombination removed the FRT-flanked lacZ and neo cassette. Cre-mediated recombination removed exon 3.
(J:240681)
|
|
|
|
Original: |
J:240681 Fonseca MI, et al., Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain. J Neuroinflammation. 2017 Mar 06;14(1):48 |
All: |
20 reference(s) |
|